ArticleMultiple sclerosis and related disorders2021

Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis.

Mark S Freedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.